The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 Disease

Area of Science:

• Biochemistry
• Pathophysiology
• Critical Care Medicine

Background:

• Severe COVID-19 is linked to endothelial damage and respiratory failure.
• Heparanase and heparan sulfate are key biomarkers of endothelial function.
• Effective risk stratification is crucial for managing critically ill COVID-19 patients.

Purpose of the Study:

• To determine if heparanase and heparan sulfate can aid in risk stratification and clinical management of severe COVID-19 patients.
• To investigate the correlation between heparanase/heparan sulfate levels and COVID-19 severity.
• To assess the utility of these biomarkers in predicting patient outcomes.

Main Methods:

• Studied 53 critically ill COVID-19 patients in intensive care.
• Measured heparanase activity and serum levels of heparanase and heparan sulfate on days one and three.
• Classified patients into four groups based on ARDS severity.

Main Results:

• Heparanase activity increased, while heparan sulfate levels decreased with increasing ARDS severity.
• Heparanase activity correlated significantly with lactate concentration.
• Biomarker levels showed a correlation with COVID-19 disease severity and patient outcomes.

Conclusions:

• Heparanase activity and heparan sulfate levels correlate with COVID-19 severity.
• These biomarkers show potential for predicting the clinical course and outcomes in COVID-19 patients.
• Further research may validate their use in clinical decision-making for severe COVID-19.